The Evidence Base
Post
A multistakeholder perspective on computable phenotypes for generating real-world evidence: can they really be standardized and reused?
In this interview with Rachel Richesson (University of Michigan), Elise Berliner (Cerner Enviza), Kevin Haynes (Janssen) and David Carrell (Kaiser Permanente Washington Health Research Institute), ...
Register with The Evidence Base for free to access this content
Already have an account? Sign in
By registering with The Evidence Base, you will receive our weekly round-up and other relevant editorial content. You can opt-out at any time. View our privacy policy here.